AXSM Jan 2025 60.000 put
| Previous Close | 4.0800 |
| Open | 4.0800 |
| Bid | 3.7000 |
| Ask | 4.4000 |
| Strike | 60.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 4.0800 - 4.0800 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 447 |
Insider Monkey15 Most Depressed States in the US
In this article, we will be taking a look at the 15 most depressed states in the US. If you are not interested in learning about the global and regional trends in the depression treatment market, head straight to the 5 Most Depressed States in the US. Global and Regional Trends in the Depression Treatment […]
Simply Wall St.Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Investors in Axsome Therapeutics, Inc. ( NASDAQ:AXSM ) had a good week, as its shares rose 2.0% to close at US$75.68...
GlobeNewswireAxsome Therapeutics to Present at Upcoming Investor Conferences
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome’s Chief Executive Officer, will participate in two upcoming investor conferences. The presentation details are as follows: RBC Capital Markets 2024 Global Healthcare Conference, on Tuesday, May 14, at 1:35 p.m. Eastern Time. Dr. Tabu
